Cargando…

The Efficacy of Different Chemotherapy Regimens for Advanced Biliary Tract Cancer: A Systematic Review and Network Meta-Analysis

Background: Although gemcitabine plus cisplatin (GP) is considered as standard chemotherapy for patients with advanced biliary tract cancer (BTC), the optimal regimen remains unknown. Methods: Using Network meta-analysis (NMA), a systematic review was conducted to find the most effective chemotherap...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Yan, Zhou, Yaoyao, Hong, Yonglan, He, Meizhi, Wei, Shuyi, Yang, Chen, Zheng, Dayong, Liu, Feiye
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6549535/ https://www.ncbi.nlm.nih.gov/pubmed/31192137 http://dx.doi.org/10.3389/fonc.2019.00441

Ejemplares similares

Efficacy and Safety of First-Line Chemotherapies for Patients With Advanced Biliary Tract Carcinoma: A Systematic Review and Network Meta-Analysis
por: Jiang, Yanfeng, et al.
Publicado: (2021)

The Most Efficacious Induction Chemotherapy Regimen for Locoregionally Advanced Nasopharyngeal Carcinoma: A Network Meta-Analysis
por: Choi, Horace Cheuk-Wai, et al.
Publicado: (2021)

The Efficacy and Safety of First-line Chemotherapies for Advanced Biliary Tract Cancer: A Network Meta-analysis
por: Zheng, Wei, et al.
Publicado: (2019)

Prognostic Significance of Sarcopenia in Advanced Biliary Tract Cancer Patients
por: Lee, Byung min, et al.
Publicado: (2020)

Efficacy and Toxicity of Three Induction Chemotherapy Regimens in Locoregionally Advanced Nasopharyngeal Carcinoma: Outcomes of 10-Year Follow-Up
por: Peng, Hao, et al.
Publicado: (2021)

HER2 Aberrations as a Novel Marker in Advanced Biliary Tract Cancer
por: Kim, Hongsik, et al.
Publicado: (2022)

Lenvatinib Beyond First-Line Therapy in Patients With Advanced Biliary Tract Carcinoma
por: Wang, Yunchao, et al.
Publicado: (2022)

The Efficacy and Safety of Apatinib Plus Camrelizumab in Patients With Previously Treated Advanced Biliary Tract Cancer: A Prospective Clinical Study
por: Wang, Dongxu, et al.
Publicado: (2021)

Adjuvant Therapy for Resectable Biliary Tract Cancer: A Bayesian Network Analysis
por: Chen, Xiuqiong, et al.
Publicado: (2021)

Recent Advances in the Mechanism Research and Clinical Treatment of Anti-Angiogenesis in Biliary Tract Cancer
por: Wang, Yue, et al.
Publicado: (2021)

PD-1 Inhibitors Could Improve the Efficacy of Chemotherapy as First-Line Treatment in Biliary Tract Cancers: A Propensity Score Matching Based Analysis
por: Gou, Miaomiao, et al.
Publicado: (2021)

Network meta-analysis of the efficacy of first-line chemotherapy regimens in patients with advanced colorectal cancer
por: Wu, Dong-Mei, et al.
Publicado: (2017)

The efficacy and safety of different pharmacological interventions for patients with advanced biliary tract cancer: A network meta-analysis
por: Sun, Xin-Fang, et al.
Publicado: (2017)

Chemotherapy for advanced biliary tract carcinoma: A meta-analysis of randomized controlled trials
por: Chen, Lawrence, et al.
Publicado: (2016)

Consolidative Chemoradiotherapy After Induced Chemotherapy Is an Optimal Regimen for Locally Advanced Pancreatic Cancer
por: Wu, Lili, et al.
Publicado: (2020)

Combining of chemotherapy with targeted therapy for advanced biliary tract cancer: A systematic review and meta-analysis
por: Bai, Xue-Song, et al.
Publicado: (2022)

Efficacy and safety analysis of chemotherapy combined with immunotherapy compared with standard chemotherapy for advanced biliary tract malignant tumors
por: Zhang, Zhengfeng, et al.
Publicado: (2023)

Current status of chemotherapy for the treatment of advanced biliary tract cancer
por: Sasaki, Takashi, et al.
Publicado: (2013)

Biliary Tract Carcinogenesis Model Based on Bile Metaproteomics
por: Arteta, Ariel A., et al.
Publicado: (2020)

Efficacy of First Line Systemic Chemotherapy and Multikinase Inhibitors in Advanced Hepatocellular Carcinoma: A Systematic Review and Network Meta-Analysis
por: Oranratnachai, Songporn, et al.
Publicado: (2021)

Clinical Efficacy and Safety of Traditional Medicine Preparations Combined With Chemotherapy for Advanced Pancreatic Cancer: A Systematic Review and Meta-Analysis
por: Hu, Jiaqi, et al.
Publicado: (2022)

Comprehensive germline and somatic genomic profiles of Chinese patients with biliary tract cancer
por: Yu, Haipeng, et al.
Publicado: (2022)

Metformin and Biliary Tract Cancer in Patients With Type 2 Diabetes
por: Tseng, Chin-Hsiao
Publicado: (2020)

The Evolving Role of Radiation Therapy in the Treatment of Biliary Tract Cancer
por: Gkika, Eleni, et al.
Publicado: (2020)

Efficacy and Safety of Chemotherapy Regimens in Advanced or Metastatic Bladder and Urothelial Carcinomas: An Updated Network Meta-Analysis
por: Qu, Hong-Chen, et al.
Publicado: (2020)

Immune checkpoint inhibitors plus capecitabine and oxaliplatin in unresectable or advanced biliary tract cancer patients: A retrospective study
por: Zhao, Jie, et al.
Publicado: (2022)

Comparison of the Efficacy between Gemcitabine-Cisplatin and Capecitabine-Cisplatin Combination Chemotherapy for Advanced Biliary Tract Cancer
por: Lee, Jieun, et al.
Publicado: (2015)

Efficacy and safety of treatment regimens for patients with metastatic, locally advanced, or recurrent breast cancer carrying BRCA1/BRCA2 pathogenic variants: A network meta-analysis
por: Zhu, Yingxuan, et al.
Publicado: (2023)

Outcomes in patients receiving palliative chemotherapy for advanced biliary tract cancer
por: Thol, Felix, et al.
Publicado: (2021)

Chemotherapy and targeted therapy for advanced biliary tract cancers: an umbrella review
por: Wang, Yaoqun, et al.
Publicado: (2023)

Chemotherapy for Biliary Tract Cancer in 2021
por: Sasaki, Takashi, et al.
Publicado: (2021)

Prognostic impact of the Controlling Nutritional Status Score in patients with biliary tract cancer: a systematic review and meta-analysis
por: Liu, Zhuoran, et al.
Publicado: (2023)

Comparison of chemotherapy regimens plus rituximab in adult Burkitt lymphoma: A single-arm meta-analysis
por: Lu, Xiaoxuan, et al.
Publicado: (2022)

Evolving Chemotherapy Free Regimens for Acute Promyelocytic Leukemia
por: Kulkarni, Uday, et al.
Publicado: (2021)

Efficacy and safety of neoadjuvant immunotherapy combined with chemotherapy in locally advanced esophageal cancer: A meta-analysis
por: Wang, Jincheng, et al.
Publicado: (2022)

Real-World Outcomes of Gemcitabine, Cisplatin, and Nab-Paclitaxel Chemotherapy Regimen for Advanced Biliary Tract Cancer: A Propensity Score-Matched Analysis
por: Jung, Kwangrok, et al.
Publicado: (2022)

The efficacy and safety of 5-fluorouracil/cisplatin/vincristine as a multi-agent chemotherapy regimen in gestational trophoblastic neoplasia
por: Wang, Lu, et al.
Publicado: (2023)

High Response Rate and Prolonged Survival of Unresectable Biliary Tract Cancer Treated With a New Combination Therapy Consisting of Intraarterial Chemotherapy Plus Radiotherapy
por: Goto, Takuma, et al.
Publicado: (2020)

Short-term efficacy of different chemotherapy regimens in the treatment of advanced gastric cancer: a network meta-analysis
por: Duo-Ji, Mi-Ma, et al.
Publicado: (2017)

The efficiency and regimen choice of adjuvant chemotherapy in biliary tract cancer: A STROBE-compliant retrospective cohort study
por: Yin, Luxi, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_0s4ceev130297d99mmajjnfao8